Back to Articles

Incorporation of inhibitory domains into chimeric antigen receptors designed to reduce on-target-off-tumor toxicity in solid tumor treatment

incorporation-bg

Bassan D, et al. Poster presentation at the Annual Meeting of the American Association for Cancer Research (AACR). April 2022

 

Connect with us on LinkedIn, or get in touch via email.

Linkedin-in Envelope
Menu
Contact

8501 Fallbrook Avenue, Suite 200

West Hills, CA 91304 USA

info@immpact-bio.com

(818) 857-4828

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

ImmPACT Bio is now part of Lyell Immunopharma

Learn More

If you have a question about a clinical trial, please contact us at info@immpact-bio.com